Kiniksa Pharmaceuticals International, Plc is an active company incorporated on 9 April 2024 with the registered office located in London, Greater London. Kiniksa Pharmaceuticals International, Plc was registered 1 year 9 months ago.
Statement of capital following an allotment of shares on 31 December 2025
Submitted on 19 Jan 2026
Statement of capital following an allotment of shares on 30 November 2025
Submitted on 16 Dec 2025
Registered office address changed from 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ England to 105 Piccadilly Second Floor London W1J 7NJ on 3 December 2025
Submitted on 3 Dec 2025
Statement of capital following an allotment of shares on 31 October 2025
Submitted on 3 Dec 2025
Registered office address changed from 105 Piccadilly 105 Piccadilly London W1J 7NJ England to 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ on 4 November 2025
Submitted on 4 Nov 2025
Registered office address changed from Third Floor 23 Old Bond Street London W1S 4PZ United Kingdom to 105 Piccadilly 105 Piccadilly London W1J 7NJ on 4 November 2025
Submitted on 4 Nov 2025
Statement of capital following an allotment of shares on 30 September 2025
Submitted on 10 Oct 2025
Appointment of Mr. Douglas Barry as a secretary on 18 September 2025
Submitted on 22 Sep 2025
Termination of appointment of Madelyn Zeylikman as a secretary on 18 September 2025
Submitted on 22 Sep 2025
Statement of capital following an allotment of shares on 31 August 2025